Angel M Carcaboso
Overview
Explore the profile of Angel M Carcaboso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
3045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balaguer-Lluna L, Olaciregui N, Aschero R, Resa-Pares C, Paco S, Cuadrado-Vilanova M, et al.
J Neurooncol
. 2025 Feb;
PMID: 39961939
Purpose: We aimed to expand and refine the experimental models for pediatric-type diffuse high grade gliomas (pHGG) and the methods to follow up disease progression in mouse pHGG xenografts. Methods:...
2.
Cancela M, Winter U, Zugbi S, Dinardi M, Alves da Quinta D, Aschero R, et al.
Invest Ophthalmol Vis Sci
. 2024 Dec;
65(14):14.
PMID: 39636723
Purpose: Refractory or recurrent retinoblastoma results from acquired chemoresistance and the management of these eyes often requires surgical removal. Our objective was to develop retinoblastoma models resistant to chemotherapy by...
3.
Panisello C, Aschero R, Martinez-Moreno A, Roca Ho H, Falgas A, Gonzalez-Navarro E, et al.
J Immunother Cancer
. 2024 Oct;
12(10).
PMID: 39379097
Humanized immunodeficient mice serve as critical models for investigating the functional interplay between transplanted human cells and a pre-reconstituted human immune system. These models facilitate the study of molecular and...
4.
Pascual-Pasto G, McIntyre B, Giudice A, Alikarami F, Morrissey A, Matlaga S, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3578-3591.
PMID: 38864848
Purpose: Retinoblastoma is the most common intraocular malignancy in children. Although new chemotherapeutic approaches have improved ocular salvage rates, novel therapies are required for patients with refractory intraocular and metastatic...
5.
Wiese M, Pohlmeier B, Kubiak K, El-Khouly F, Sitte M, Carcaboso A, et al.
J Tradit Complement Med
. 2024 Jan;
14(1):101-108.
PMID: 38223806
Background And Aim: Pediatric high-grade gliomas (pedHGG) comprise a very poor prognosis. Thus, parents of affected children are increasingly resorting to complementary and alternative medicine (CAM), among those Boswellia extracts....
6.
Brown E, Balaguer-Lluna L, Cribbs A, Philpott M, Campo L, Browne M, et al.
Sci Rep
. 2024 Jan;
14(1):328.
PMID: 38172189
H3K27-altered Diffuse Midline Glioma (DMG) is a universally fatal paediatric brainstem tumour. The prevalent driver mutation H3K27M creates a unique epigenetic landscape that may also establish therapeutic vulnerabilities to epigenetic...
7.
Zugbi S, Aschero R, Ganiewich D, Cancela M, Winter U, Ottaviani D, et al.
Invest Ophthalmol Vis Sci
. 2023 Dec;
64(15):27.
PMID: 38117242
Purpose: Although there have been improvements in the management of metastatic retinoblastoma, most patients do not survive, and all patients suffer from multiple short- and long-term treatment toxicities. Reliable and...
8.
9.
Aschero R, Ganiewich D, Lamas G, Restrepo-Perdomo C, Ottaviani D, Zugbi S, et al.
Pediatr Blood Cancer
. 2023 Oct;
71(1):e30717.
PMID: 37814421
Introduction: The risk of relapse in retinoblastoma is currently determined by the presence of high-risk histopathologic factors in the enucleated eye. However, the probability of developing metastatic disease is heterogeneous...
10.
Lee K, Yun S, Park J, Lee S, Carcaboso A, Yi S, et al.
Biochem Biophys Res Commun
. 2023 Jul;
677:6-12.
PMID: 37523894
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric brain tumor with limited therapeutic options. Here, we investigated the potential of dimethyl alpha-ketoglutarate (DMKG) as an anti-proliferative agent against...